SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-015505
Filing Date
2019-08-06
Accepted
2019-08-05 19:14:18
Documents
66
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20190630_10q.htm 10-Q 1299742
2 EXHIBIT 10.2 ex_151961.htm EX-10.2 12007
3 EXHIBIT 31.1 ex_151965.htm EX-31.1 9426
4 EXHIBIT 31.2 ex_151964.htm EX-31.2 10360
5 EXHIBIT 32.1 ex_151963.htm EX-32.1 6842
  Complete submission text file 0001437749-19-015505.txt   5587302

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acrx-20190630.xml EX-101.INS 1167610
7 XBRL TAXONOMY EXTENSION SCHEMA acrx-20190630.xsd EX-101.SCH 60250
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20190630_cal.xml EX-101.CAL 43936
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20190630_def.xml EX-101.DEF 329133
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20190630_lab.xml EX-101.LAB 315772
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20190630_pre.xml EX-101.PRE 357823
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 191000053
SIC: 2834 Pharmaceutical Preparations